Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of NT-88 [NA]

View source ↗

Summary

Clinical trial update: NT-88 is being studied to assess safety and efficacy in heart failure with mildly reduced ejection fraction; the trial is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Mildly Reduced Ejection Fraction

Drugs mentioned

• NT-88

Snippet

Sponsor: Guangzhou Manjing biomedicine technology co., ltd | Conditions: Heart Failure With Mildly Reduced Ejection Fraction | NA | Status: NOT_YET_RECRUITING